Author:
Casati Sara,Ellul Bridget
Abstract
Paediatric translational research deals mainly with genomics of biological samples. It has benefitted substantially from developments in new technologies and from international collaboration to access and use large cohorts of banked biological samples and associated data. However, there are still significant ELSI (ethical, legal and societal implications) challenges that need to be addressed before we can move smoothly from the “bench” to the “bedside” to the “community”. In this chapter we shall concentrate on the intertwined ethical and legal issues regarding informed assent/consent of minors and the return of genomic results to minors and families. This leads to the societal issues faced in minor engagement and empowerment. We will then emphasise the need for healthcare integrated biobanking to maximise use of samples and data and so facilitate translational research.
Reference89 articles.
1. Cohrs RJ, Martin T, Ghahramani P, Bidaut L, Higgins SA. Translational medicine definition by the European society for translational medicine. New Horizons in Translational Medicine. 2015;(3):86-88. DOI: 10.1016/j.nhtm. 2014.12.002
2. EPTRI Manifesto. Available from: [Accessed: June 2, 2023]
3. Fort DG, Herr TM, Shaw PL, Gutzman KE, Starren JB. Mapping the evolving definitions of translational research. Journal of Clinical and Translational Science. 2017;(1):60-66. DOI: 10.1017/cts.2016.10. Epub 2017 Feb 2
4. United Nations. Convention on the Rights of the Child, Adopted and Opened for Signature, RatiFication and Accession by General Assembly Resolution 44/25 of 20 November 1989, Entry into Force 2 September 1990, in Accordance with Art 49. New York, USA: United Nations; 1989. Available from: ; [Accessed: June 2, 2023]
5. United Nations. Geneva, Switzerland: Office of the High Commissioner of Human Rights (OHCHR); 1996-2014. Available from: [Accessed: June 2, 2023]